Cantabio Pharmaceuticals, Inc.
OTC: CTBO0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Gergely Tóth
- Employees
- 451
- Headquarters
- Palo Alto, United States
- IPO year
- 1995
- Market cap
- $22.8K
- Website
- http://www.cantabio.com
Loading CTBO…
Loading profile data…Frequently asked questions about CTBO
What does Cantabio Pharmaceuticals, Inc. (CTBO) do?
Cantabio Pharmaceuticals, Inc. is a preclinical stage biotechnology company, which engages in the commercialization of novel therapies and the intellectual property generated from the research and development activities for Parkinson's, Alzheimer's diseases, and any other related diseases. It focuses on identification and development of small mo...
Where does CTBO trade?
Cantabio Pharmaceuticals, Inc. (CTBO) trades on the Other OTC.
What sector is CTBO in?
Cantabio Pharmaceuticals, Inc. (CTBO) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Cantabio Pharmaceuticals, Inc.?
Gergely Tóth is the chief executive officer of Cantabio Pharmaceuticals, Inc. (CTBO).
Where is Cantabio Pharmaceuticals, Inc. headquartered?
Cantabio Pharmaceuticals, Inc. is headquartered in United States.
Does CTBO pay a dividend?
Cantabio Pharmaceuticals, Inc. (CTBO) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did CTBO go public?
Cantabio Pharmaceuticals, Inc. (CTBO) completed its initial public offering in 1995.